Glatiramer acetate and therapeutic peptide vaccines for multiple sclerosis

Introduction Most vaccines are used for prophylaxis of disease; however, therapeutic vaccination involves the use of an antigen-specific intervention to inhibit an unwanted immune response, with the goal of preventing progression of, or eliminating, existing disease [1]. Effective therapeutic vaccines are less common than preventive vaccines and are more challenging to